Search - tctmd.com

Displaying 21 - 40 of 73

Sort: Relevancy | Date

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

September 22, 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

September 20, 2022

TCT 647: Single Pedal access for revascularization of critical limb ischemia: A challenging case of a unilateral pedal-to-pedal intervention

Presentation TCT 2022

TCT 647: Single Pedal access for revascularization of critical limb ischemia: A challenging case of a unilateral pedal-to-pedal intervention

Presenter: Mohammed Salih

September 19, 2022

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

Presentation TCT 2022

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

Presenter: Janneke Woudstra

September 18, 2022

TCT 263: Viability and ischemia assessment in chronic coronary total occlusions according to collaterals distribution: a stress CMR study

Presentation TCT 2022

TCT 263: Viability and ischemia assessment in chronic coronary total occlusions according to collaterals distribution: a stress CMR study

Presenter: Mauro Chiarito

September 17, 2022

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

News Conference News ESC 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

September 01, 2022

September 2022 News Roundup

News Opinion CV Team Dispatch

September 2022 News Roundup

September 01, 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

August 29, 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

What’s Going to Be Hot at ESC 2022?

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

August 22, 2022

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

News Daily News

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

August 19, 2022

Worse Complications After PVI in Women Highlight Research Gaps

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

August 16, 2022

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

August 15, 2022

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

August 11, 2022

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

August 05, 2022

August 2022 News Roundup

News Opinion CV Team Dispatch

August 2022 News Roundup

August 01, 2022

High Lp(a) May Predict Risk of CV and Limb Events in PAD

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

July 18, 2022

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.